RN7SL614P

Across TCGA pan-cancer cohorts, RN7SL614P RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated RN7SL614P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RN7SL614P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL614P expression acts as an unfavorable survival marker, although some lineages such as MESO and BLCA show a favorable association.

ACC, MESO, and CHOL are the cancer types where RN7SL614P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	III,IV	0.300	0.731	<.001	63	view →
MESO	OS	Median	All	0.645	0.440	.003	40	view →
CHOL	OS	Median	III,IV	0.286	1.000	.008	38	view →
LUAD	DFS	Quartile	IV	0.587	0.911	.005	27	view →
LGG	DFS	Median	All	0.304	0.480	<.001	21	view →
BLCA	OS	Tertile	III,IV	0.727	0.486	.015	20	view →
READ	DFS	Quartile	All	0.937	0.469	.010	14	view →
KIRC	OS	Median	All	0.911	0.848	.010	11	view →
SARC	OS	Quartile	All	0.925	0.810	.005	11	view →
KIRP	DFS	Quartile	IV	0.028	0.456	.001	10	view →
THCA	OS	Quartile	II,III,IV	0.900	0.981	.020	8	view →
UCEC	DFS	Median	All	0.544	0.681	.006	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

RN7SL614P–ACC (DFS)

Open the ACC breakdown →